Congress Calls for GAO Probe into Medicare Advantage Plan Acquisitions
U.S. Representatives urge a probe into Medicare Advantage plans acquiring health businesses, potentially affecting compliance with medical loss ratio standards.
Peterson Center Report Evaluates RPM and RTM in Medicare, Suggests Reforms
Explore the key findings from the Peterson Center on Healthcare's latest report on Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM), suggesting essential reforms for Medicare.
U.S. Insurance Industry Trends: Notable Updates on Prior Authorization
Explore significant updates in the U.S. insurance industry related to prior authorization, including federal and state legislative shifts, and the deployment of AI technology.
Medicare Advantage in Upstate New York Faces Financial Strain Amid Wage Index Changes
In upstate New York, Medicare Advantage plan beneficiaries face possible cuts in benefits and increases in costs due to changes in the Medicare wage index. Learn about the legislative efforts to mitigate this issue.
CMS Confirms Major Changes to Medicare Advantage Policies for 2026
Discover the latest changes in Medicare Advantage policies announced by CMS for 2026, highlighting new compliance standards and efforts to improve healthcare integration and quality.
Medicare Advantage Plans Under Scrutiny for Misleading Marketing Practices
Cobi Blumenfeld-Gantz testified before the Senate Finance Committee, discussing misleading marketing practices in Medicare Advantage plans, spotlighting the need for stricter regulatory oversight.
Pathlight Capital Facilitates $210M Credit Facility to Boost Spring Venture Group
Pathlight Capital becomes the Administrative Agent for a $210M credit facility for Spring Venture Group, enhancing its position in the Medicare brokerage sector.
Key Developments in U.S. Medicare Policy: Executive Orders, Market Adaptations, and Legislative Advocacy
Explore recent U.S. Medicare policy changes including Trump's executive orders to lower healthcare costs and legislative advocacy to cover anti-obesity drugs, alongside market developments involving Humana and Cone Health.
CMS Issues Transformative Final Rule for Medicare Programs Effective 2026
The CMS final rule effective 2026 will modernize Medicare Advantage and Part D, enhancing drug coverage and establishing more robust regulatory frameworks.
Pathlight Capital Provides $210M Credit Facility to Spring Venture Group
Pathlight Capital serves as the Administrative Agent in a $210 million credit facility for Spring Venture Group, fueling expansion in the Medicare insurance sector. Discover more about this strategic financing solution and its impact on the insurance market.